Athens Greece, 29 November 2021 – Funds managed by ECM Partners (“ECM”) and Metric Capital Partners LLP (“MCP”) are pleased to announce a new investment in FAMAR (“FAMAR” or the “Company”), a European contract development and manufacturing organisation serving the pharmaceutical sector.
Funds managed by ECM acquired FAMAR in March 2020 with a view of making the necessary investments to improve performance. Since then, FAMAR has seen material improvements in service and quality and the Company is now operating in line with the quality and services levels expected by its customer base.
Savvas Liasis, Chairman and Co-Managing Partner at ECM, said: “We’re extremely pleased with FAMAR’s operational performance since making our initial investment. The results speak for themselves, and customer feedback has been very positive. Increasing our stake in the company to a majority equity position was the natural development for us, as we now take a longer term view of the firm.”
As part of the most recent transaction, ECM has increased its investment and ownership in FAMAR, while MCP has made a significant investment in FAMAR and expects to support the Company’s ambitions over the coming years. York Capital Management has realised its investment in the Company.
John Sinik, Managing Partner of MCP, said: “We are pleased to be partnering with ECM and FAMAR’s management team to take the Company to the next level. Together, we are taking a long-term view and will work with FAMAR’s customers and stakeholders to grow the business in exciting areas. We can make significant investments to build out FAMAR’s capabilities over the coming years.”